In this exclusive clip from early in "The Seventh Day," Guy Pearce's Costello gives Garcia the rundown on why his early exocrist experience made the paranormal personal for him.
In this exclusive clip from early in "The Seventh Day," Guy Pearce's Costello gives Garcia the rundown on why his early exocrist experience made the paranormal personal for him.
The intro of "Texans 360" no longer features any major highlights of Deshaun Watson.
Edmonton has made a small move to shore up the defense ahead of the NHL trade deadline.
The Korean American actor and producer talks about his upbringing and wanting better for his own children.
Allegra Angelo says she wants to be your personal sommelier, Miami.
A drug that helps the immune system fight cancer gave dramatic results when used with chemotherapy before surgery in patients with operable lung tumors, doctors report. One out of 4 patients given chemo and the Bristol Myers Squibb drug Opdivo had no signs of cancer remaining once they ultimately had surgery, a study of about 350 such people found. “They open the person up and the tumour’s just melted away. It’s incredible,” said Dr. Roy Herbst, a lung specialist at the Yale Cancer Center. He had no role in the study, whose results were reported Saturday at an American Association for Cancer Research conference, but has consulted for the maker of Opdivo and other cancer drugs. Lung cancer kills more than 1.7 million people globally each year. Only about one-third of cases are caught early enough for surgery to help, but that’s still about 70,000 patients each year in the United States and the number is growing as screening former or current heavy smokers expands, Herbst said. Opdivo and similar drugs called checkpoint inhibitors work by removing a cloak that some cancer cells have that hides them from the immune system. They’re often used now for various cancers after surgery, and many studies are testing them before surgery as well. Dr. Patrick Forde at Johns Hopkins University led one such study of about 350 patients with lung cancers that had not spread widely. The cancers were not the type that can be treated with drugs that target certain gene mutations. Patients were given three rounds of chemo and Opdivo several weeks apart or chemo alone. When they had surgery, no cancer remained in 24% of those given the combo versus 2.2% of those who received just chemo. Whether the combo treatment improves survival remains to be seen; the study is continuing. “This is a great next step” for furthering the immune system’s ability to attack lung cancer, said Dr. Antoni Ribas, a cancer specialist at the University of California, Los Angeles, and president of the group sponsoring the conference. Seeing no evidence of disease at surgery in 1 in 4 patients means they “had an immune system that was really ready to go” with proper prodding, he said. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. Marilynn Marchione, The Associated Press
Karina W. Davidson, PhD, MASc, The Feinstein Institutes for Medical Research director of the Institute of Health System Science and Northwell Health senior vice president of research, has been appointed as chair of the U.S. Preventive Services Task Force (USPSTF or Task Force).
Across the U.S., 1 in 3 taxpayers are waiting until the deadline to file, according to a survey of 1,002 people by IPX 1031.
West Virginia has opened its arms -- and its wallet -- to lure in remote workers.
TORONTO, April 12, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces that its Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021 will be adjourned to a future date. Due to the current provincial lockdown in response to the COVID-19 pandemic, the Meeting was to be held by way of conference call. Due to the high shareholder turnout and interest, the service provider contracted to arrange the conference call experienced technical difficulties with the bridge facilities. In order to ensure that all shareholders are able to attend and participate at the Meeting, the Company has decided to adjourn the Meeting in order to procure enhanced conference facilities. A subsequent press release will be disseminated with the updated call-in information. About Revive Therapeutics Ltd. Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on COVID-19. With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the company was granted FDA orphan drug status designation for the use of Cannabidiol to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation. For more information, visit www.ReviveThera.com. For more information please contact: Michael FrankChief Executive OfficerRevive Therapeutics Ltd. Tel:1 888 901 0036Email:firstname.lastname@example.org Website:www.revivethera.com Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
EDMONTON — The head of the Alberta Medical Association says many factors led to the recent collapse of a proposed master agreement with the province, but he says a key one was lack of trust. Dr. Paul Boucher says before he and Health Minister Tyler Shandro can even begin negotiating the nuts and bolts of a new deal, that trust must be regained. “I’m not going to bring back another agreement (for ratification) unless I have pretty good confidence that it’s going to pass,” Boucher said in an interview. “Another failed ratification would be a disaster for everyone as far as I’m concerned.” Boucher said he and Shandro are meeting again, almost two weeks after the rank-and-file physicians of the 11,000-member AMA refused to ratify the new tentative deal brokered by both sides, voting 53 per cent against it. Boucher said normally such deals pass with a strong majority. But during the voting process, he said he heard from about 3,000 physicians and many told him their core concern was that the pact left them too exposed to a government they didn’t trust. “Any agreement really requires both parties to work well together within it,” said Boucher. “I think a lot of members just weren’t sure that this was going to be the case. And there wasn’t enough clarity or safeguards to ensure that their voices were going to be heard and that they would be treated fairly within it. “That’s a result of the challenges we’ve had (with the province) over the year.” Those challenges began in early 2020, when Shandro unilaterally tore up the master agreement with the AMA, using a law passed months prior by the United Conservative government. That cancellation launched a year of bitter attacks from both sides. Shandro imposed fee changes that led to some doctors withdrawing services, particularly in rural locations, saying the changes were financially unsustainable. Shandro’s officials dismissed the AMA as a lobby group and Shandro accused the organization of spreading misinformation to its members. The AMA, in turn, sued the government, accusing it of violating Charter rights on collective bargaining by, among other things, cancelling binding arbitration. All this was going on as COVID-19 swept through the province, filling up hospital wards. Boucher said doctors were ready to sign a deal for less money, although they still had concerns and questions over remuneration. The deal would have imposed an annual ceiling of about $4.6 billion, almost a billion dollars less than currently budgeted. But he said a key concern was that binding arbitration had been replaced by mediation, albeit with the mediation decision made public. In addition, the AMA lawsuit would be cancelled. The AMA considers binding arbitration critical, given it can’t hit the picket line for ethical reasons to otherwise gain leverage on intractable labour disagreements. “(Arbitration) guarantees you a process. It does not guarantee you a result on either end, but I think a lot of docs just wanted that sense of fairness,” said Boucher. “And I would have loved to have given it to them. We just couldn’t get that this go round.” He said Shandro and the government have pivoted from the former approach and have been working collaboratively with the AMA, particularly on the recent COVID-19 vaccine rollout. Shandro has cancelled many of the fee changes he imposed and promised contentious ones won’t ever return. After the vote failed on March 30, Shandro stated, “Our government will seek to further renew our relationship with the AMA in the weeks and months to come as we work together to ensure Albertans continue to benefit from quality health care.'' Boucher agreed: “We just need to rebuild the relationship.” He said there is no timeline for a new deal. “I think it’s going to be some time." This report by The Canadian Press was first published April 12, 2021. Dean Bennett, The Canadian Press
Stocks wobbled between small gains and losses in afternoon trading Monday after the market hit record highs last week. Investors are continuing to focus on the economic recovery as well as concerns about inflation and rising bond yields. The S&P 500 index mostly unchanged as of 12:40 p.m. Eastern. The Dow Jones Industrial Average fell 41 points, or 0.1%, to 33,761 and the Nasdaq Composite fell 0.3%. Technology stocks were the biggest drag on the market. The sector has been choppy as investors shift money to other industries that could see solid gains as the economy recovers. Rising bond yields have also made technology stock values look pricey after months of big gains. The slide by technology companies offset gains from banks and a broad mix of companies that rely directly on consumer spending, including Nike and Chipotle. Wall Street will be watching company earnings reports this week, particularly several from big banks. JPMorgan Chase and Wells Fargo report on Wednesday, while Bank of America and Citigroup report on Thursday. Investors expect big profits for the major banks, mostly due to rising interest rates and the ability for these banks to move loans that went bad in the early weeks of the pandemic back onto the “good” side of their balance sheets. The yield on the 10-year U.S. Treasury note, which influences interest rates on mortgages and other loans, held steady at 1.67%. It ended Friday at 1.66% and had been as high as 1.75% last Monday. Investors are showing cautious optimism about the economic recovery, especially in the U.S., where vaccine distribution as been ramping up and President Joe Biden has advanced the deadline for states to make doses available to all adults to April 19. Nuance Communications soared 16% after Microsoft said it would buy the speech technology company for about $16 billion. Alibaba's U.S.-listed shares rose 8.7% after the Chinese conglomerate said it would restructure its Ant Group financial affiliate to placate Chinese government regulatory concerns. Damian J. Troise, The Associated Press
Sam and Bucky vs. John Walker.
Toronto's top doctor says that at the current rate of transmission the city could see 2,500 new COVID-19 cases per day by the end of April. Medical officer of health Dr. Eileen de Villa says the surging rates are being driven by more transmissible variants of concern in the community. De Villa says the current record for daily cases in Toronto is 1,642 and was set during the second wave of the pandemic. She says the city is vaccinating more people against the virus but that still won't be enough to offset the impact of the variants. De Villa says people are moving less since the new stay-at-home order has come into effect, but not in every part of the city. Overall, the province is reporting 4,401 new cases of COVID-19 today, and 15 new deaths due to the virus. Health Minister Christine Elliott said there are 1,282 new cases in Toronto, 772 in Peel Region, 564 in York Region, 339 in Ottawa and 224 in Durham. The province said it has conducted 47,929 tests since the last daily report. In total, 1,646 people are hospitalized in Ontario due to COVID-19, including 619 in intensive care, and 408 people are on ventilators. Ontario has administered 74,722 doses of the vaccine since its last daily update, with 3,214,465 vaccines given in total. The latest figures bring the total number of COVID-19 cases in Ontario to 391,009, with 7,567 deaths, and 348,684 cases resolved. Meanwhile, hospitals in the province started ramping down elective surgeries and non-urgent procedures Monday to ensure they have the capacity to treat more COVID-19 patients. Hospitals in northern Ontario are exempt from cancelling non-urgent procedures but a memo from Ontario Health last week said they should prepare to ramp down quickly in the near future. The memo also asked hospitals to identify staff who may be redeployed to other sites if necessary. Premier Doug Ford is set to make an announcement Monday afternoon along with Education Minister Stephen Lecce. The announcement comes on the first day of a postponed spring break for schools. Ford said last week that education workers who live or are employed in hot spot neighbourhoods in Toronto and Peel Region will be eligible for vaccines starting this week, with plans to expand to other hard-hit areas as supply allows. The government is also expanding the number of pharmacies administering the Oxford-AstraZeneca vaccine to people aged 55 and over this week. An additional 700 pharmacies are now offering the vaccine, with another 100 expected to join the immunization campaign by the end of April. In Toronto, the city is opening three more COVID-19 vaccination clinics – in the Cloverdale Mall, the North Toronto Memorial Community Centre and the Carmine Stefano Community Centre. Toronto residents born in 1961 or earlier, or who are at least 50 years old and live in a hot spot neighbourhood, can book a shot at one of the city-run clinics by phone or internet. Officials say 758,882 doses of a COVID-19 vaccine have been administered in Toronto so far. This report by The Canadian Press was first published April 12, 2021. The Canadian Press Note to readers: This is a corrected story. A previous version gave an incorrect tally of vaccines administered in Toronto.
Dallas, Texas--(Newsfile Corp. - April 12, 2021) - Puration, Inc. (OTC Pink: PURA) today announced a management update scheduled April 20th, 2021 to follow the upcoming FY2021 Annual Report coming later this week.The update will highlight PURA's commitment to striking on an opportunity to increase its ownership in Alkame Holdings, Inc. above its recently acquired %5 interest.The PURA management update will provide even more thorough details on the Farmersville groundbreaking planned for this summer ...
The Brooklyn Center Police Department conducts a press conference after 20-year-old Daunte Wright was killed during a traffic stop on Sunday.
Las Vegas, NV, April 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with bi-coastal processing centers, shows that new research is being made in the legalization of cannabis products that could present a significant improvement in public health and wellness. The general support by both the public and lawmakers for the legalization of marijuana has increased significantly in recent years. As we learn more about the potential benefits that could impact our communities, government officials and citizens have joined forces to encourage the consideration of decriminalizing marijuana usage. Hemp Inc. is working to make a difference and spread awareness of the life and health-saving benefits that come along with the legalization and responsible use of marijuana. The criminalization of cannabis has a long history of detrimental effects that we have the ability to remedy by changing course and how we view the use of medicinal and recreational cannabis. According to economists D. Mark Anderson and Daniel I. Rees, studies have shown and concluded that legalizing cannabis products can have a positive impact on public health. Their paper that has been published by the National Bureau of Economic Research indicates that there are a few primary components that should be addressed in the consideration of marijuana legalization. Experts believe that there are three key factors that will be heavily impacted by the legalization of cannabis products: ● Tobacco usage ● Alcohol consumption ● Violent crime rates Although marijuana consumption is not void of its own consequences, it is important to consider the fact that the use of marijuana has never directly caused an illness leading to death. Tobacco, on the other hand, accounts for approximately 150,000 deaths in the United States each year. Studies have shown that the inhalation of tobacco products has a direct correlation to lung cancer, while marijuana has had no such proven effect. The goal here is to heavily reduce the habit of smoking cigarettes in favor of a less detrimental option such as smoking cannabis. The over-consumption of alcohol has long been a contributor in preventable deaths in the United States. Approximately 95,000 US citizens perish each year as a result of alcohol use. Studies are finding that there is a thirteen to fifteen percent decrease in alcohol consumption and related deaths in correlation with the legalization of marijuana in some areas. For many years, violent drug-related crime has been traced back to the criminalization of cannabis. Since legal dispensaries began opening up, we have seen a decrease of up to nineteen percent in violent crime rates including rape and theft. To aid in promoting the health benefits of legal cannabis, Hemp Inc. is working to provide widespread education on the medicinal benefits to marijuana use. Hemp Inc. has a variety of new medicinal products under their King of Hemp line to address a multitude of public health concerns that can be remedied in part with the use of cannabis products. The enterprise is working on a plan to construct display booths at all of the upcoming concerts and events at the Veteran Village Kins Communities. In addition to their display booths, Hemp Inc. will be making their King of Hemp line available at retail stores across America later this year. For those who prefer shopping online, King of Hemp products are currently available at NaturalExposureCBD.com. Included in the King of Hemp line are items such as Bubba Kush hemp, CBD pre-rolls, fortified CBD pre-rolls, CBD and CBG Caviar and Moon Rocks, as well as Diamonds, which are the only product on the market today that contain 96%-98.7% CBD. To learn more, go to the King of Hemp® website, here. According to Hemp Inc. executives, a distributor is selling a very limited number of signed Billy Hayes CBG pre-rolls as a collector’s item. Also available are CBD pre-rolls that are signed by Bruce Perlowin, and next in the series will be the Notorious Smith Brothers. Those items will be announced and sold at a later date. In addition to their pre-rolls, the King of Hemp line also includes tinctures that contain full-spectrum hemp oil that has been extracted from the flowers and leaves of sustainably sourced hemp plants. All King of Hemp products are compliant with the Colorado Department of Agriculture regulations and all CBD products contain 0.3% or less THC and are compliant with the 2018 Farm Bill. Those interested in King of Hemp® pre-rolls; hemp-derived CBD tinctures; Caviar; Diamonds; can visit www.kingofhempusa.com and email email@example.com. WHAT IS HEMP, INC.? What is Hemp, Inc.? With a deep-rooted social and environmental mission at its core, Hemp, Inc. seeks to build a business constituency for the American small hemp farmer, the American veteran, and other groups experiencing the ever-increasing disparity between tapering income and soaring expenses. The Company is on a mission to be a powerful engine for social change and economic revival, worldwide, by providing hemp products that are eco-friendly, sustainable and healthy. Hemp, Inc. executives believe there can be tangible benefits reaped from adhering to a corporate social responsibility plan. FORWARD-LOOKING DISCLAIMER AND DISCLOSURES This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. The Securities and Exchange Commission (SEC) requires issuers to provide “adequate current information” and Hemp, Inc. does… using the SEC’s Alternative Reporting Standard to publicly report its quarterly and yearly financials. All current information can be found on www.hempinc.com/hemp-financial-disclosures/. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. Contact Name: Hemp, Inc. Phone: 855-436-7688 Email: firstname.lastname@example.org
Paula Abdul is returning to the “American Idol” family. For the first time since the singing competition show was revived on ABC, Abdul will return to guest judge after series host Luke Bryan tested positive for COVID-19. He is currently recovering while in quarantine, ABC announced on Monday morning. Bryan’s positive diagnosis means he will […]
CORNER BROOK, N.L. — A Newfoundland and Labrador health authority is investigating whether there is community spread of COVID-19 in the western region of the province. The health agency issued a news release Sunday urging residents of Corner Brook, N.L., and the Bay of Islands, N.L., area to get tested even if they don't have symptoms. "The purpose of these (testing) clinics is to get a snapshot of possible transmission within the community, the Health Department said. "If further action is necessary, residents will be advised." The plea for testing came after officials reported five cases in the region over the weekend and three others late last week. On Monday, health officials said contact tracers were still trying to determine the source of one of those infections. The source of another infection announced Thursday in the eastern region of the province is also still under investigation, according to public health. No new infections were reported in Monday's news release. The province has 10 active reported cases of COVID-19: eight in the western region and two in the eastern region. This report by The Canadian Press was first published April 12, 2021. The Canadian Press
CALGARY — In another sign of ongoing Canadian oilpatch consolidation, Tamarack Valley Energy Ltd. says it has agreed to buy private Anegada Oil Corp. for a net $494 million. The Calgary-based oil and gas producer says it will pay $248 million in cash and assumed debt (after deducting proceeds from a royalty sale) and issue about $246 million in shares at a deemed price of $2.34 each for Anegada, which produces about 11,800 barrels of oil equivalent per day from the Charlie Lake area of northwestern Alberta. Tamarack Valley also says it has sold a two per cent royalty on its Charlie Lake assets for $32 million to Topaz Energy Corp., a company created by Tourmaline Oil Corp. to hold petroleum processing and handling assets and taken public in a $250-million initial public offering in October. Last month, Tamarack Valley announced the close of two other acquisitions for about $135 million, including the purchase of private Woodcote Petroleum Inc. for cash and shares. The deals were backed by the sale of two four-per-cent royalties to Topaz. At the same time, Tamarack Valley issued 30.3 million shares for gross proceeds of about $68 million. Tamarack Valley said Monday its 2021 capital budget has been raised from about $127 million to $170 million and it expects to have average production this year of 33,000 boe/d, up from 26,000 boe/d. "Our strategic portfolio approach of investing in high impact oil plays, combined with a focus on decline mitigation through our waterflood assets, enhances corporate free cash flow sustainability and resiliency," said Tamarack Valley CEO Brian Schmidt. This report by The Canadian Press was first published April 12, 2021. Companies in this story: (TSX:TVE, TSX:TPZ) The Canadian Press
Vancouver, British Columbia--(Newsfile Corp. - April 12, 2021) - Couloir Capital Ltd. is pleased to announce initiation of research coverage on Maple Gold Mines Ltd. (TSXV: MGM) (OTCQB: MGMLF). The report is titled, "Gold Explorer Ties Up with Agnico Eagle Mines to Explore Large Gold Property with District-Scale Potential."About Maple Gold Mines Ltd.Maple Gold Mines Ltd. (TSXV: MGM) (OTCQB: MGMLF) ("MGM", or "Company") is a junior mining company with a focus on precious ...